| English |
|---|
| Title | Adrenal Scintigraphy Using 123I Labeled 6β-Iodomethyl-19-Norcholest-5(10)-EN-3β-OL(NCL-6-123I) |
|---|
| Subtitle | |
|---|
| Authors | I.KAMOI*, Y.OSHIUMI*, Y.TATENO**, F.SHISHIDO**, T.IDO**, K.SUZUKI**, T.IRIE**, K.FUKUSHI**, C.NAKAYAMA*, K.MATSUURA*, T.ITOH***, H.OGAWA***, M.MAEDA****, M.KOJIMA**** |
|---|
| Authors(kana) | |
|---|
| Organization | *Faculty of Medicine, Kyushu University, **Clinical Division, National Institute of Radiological Science, ***Daiichi Radioisotopes Laboratories Ltd., ****Faculty of Pharmaceutical Sciences, Kyushu University |
|---|
| Journal | The Japanese Journal of nuclear medicine |
|---|
| Volume | 17 |
|---|
| Number | 4 |
|---|
| Page | 389-393 |
|---|
| Year/Month | 1980/5 |
|---|
| Article | Original article |
|---|
| Publisher | THE JAPANESE SOCIETY OF NUCLEAR MEDICINE |
|---|
| Abstract | Abstract NCL-6-123I was used as an adrenal imaging agent for four patients, in each of whom the adrenal glands were clearly imaged. Scintigraphy was performed 48-72 hours after the intravenous injection of NCL-6-123I. In this series, useful informations of adrenal glands were obtained in a short interval. The absorbed radiation dose using NCL-6-131I is far less than that with NCL-6-131I. NCL-6-123I is therefore considered a potential adrenal scanning agent for a future clinical use. |
|---|
| Practice | Clinical medicine |
|---|
| Keywords | Adrenal Scintigraphy, Iodine 123, NCL-6-123I |
|---|
| Japanese |
|---|
| Title | 123I標識6β-Iodomethyl-19-Norcholest-5(10)-EN-3β-OL(NCL-6-123I) による副腎シンチグラフィの臨床評価 |
|---|
| Subtitle | 原著 |
|---|
| Authors | 鴨井逸馬*, 鴛海良彦*, 舘野之男*, 宍戸文男**, 井戸達雄**, 鈴木和年**, 入江俊章**, 福士清**, 仲山親*, 松浦啓一*, 伊藤隆之***, 小川弘***, 前田稔****, 小島正治**** |
|---|
| Authors(kana) | |
|---|
| Organization | *九州大学医学部放射線科学教室, **放射線医学総合研究所, ***第一ラジオアイソトープ研究所, ****九州大学薬学部放射性薬品学教室 |
|---|
| Journal | 核医学 |
|---|
| Volume | 17 |
|---|
| Number | 4 |
|---|
| Page | 389-393 |
|---|
| Year/Month | 1980/5 |
|---|
| Article | 原著 |
|---|
| Publisher | 日本核医学会 |
|---|
| Abstract | 6β-Iodomethyl-19-Norcholest-5(10)-EN-3β-OL(NCL-6)に小島らの方法を用い, 放医研製123Iによる標識を行ったNCL-6-123Iを得た. NCL-6-123Iを用い臨床例4例に副腎シンチグラフィを行い, 静脈注射より48時間より72時間後に良好な副腎シンチグラムが得られた. シンチ所見を臨床的最終診断と比較することにより分析を行ない, 臨床的有用な情報を得た. 従来用いられている131I標識-NCLに比し被曝線量も軽減出来, 今後用いられるべき副腎シンチグラフィ用放射性医薬品であると考える. |
|---|
| Practice | 臨床医学：一般 |
|---|
| Keywords | Adrenal Scintigraphy, Iodine 123, NCL-6-123I |
|---|